Does OXALIPLATIN Cause Diffuse large b-cell lymphoma recurrent? 189 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 189 reports of Diffuse large b-cell lymphoma recurrent have been filed in association with OXALIPLATIN (Oxaliplatin). This represents 0.3% of all adverse event reports for OXALIPLATIN.
189
Reports of Diffuse large b-cell lymphoma recurrent with OXALIPLATIN
0.3%
of all OXALIPLATIN reports
13
Deaths
19
Hospitalizations
How Dangerous Is Diffuse large b-cell lymphoma recurrent From OXALIPLATIN?
Of the 189 reports, 13 (6.9%) resulted in death, 19 (10.1%) required hospitalization, and 2 (1.1%) were considered life-threatening.
Is Diffuse large b-cell lymphoma recurrent Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for OXALIPLATIN. However, 189 reports have been filed with the FAERS database.
What Other Side Effects Does OXALIPLATIN Cause?
Diarrhoea (4,963)
Nausea (4,250)
Neuropathy peripheral (3,662)
Off label use (3,603)
Neutropenia (3,391)
Vomiting (3,383)
Disease progression (3,370)
Thrombocytopenia (2,886)
Dyspnoea (2,779)
Pyrexia (2,269)
What Other Drugs Cause Diffuse large b-cell lymphoma recurrent?
RITUXIMAB (1,359)
CYCLOPHOSPHAMIDE (1,007)
VINCRISTINE (957)
DOXORUBICIN (953)
PREDNISONE (738)
CYTARABINE (406)
DEXAMETHASONE (402)
ETOPOSIDE (375)
CISPLATIN (306)
GEMCITABINE (280)
Which OXALIPLATIN Alternatives Have Lower Diffuse large b-cell lymphoma recurrent Risk?
OXALIPLATIN vs OXAPROZIN
OXALIPLATIN vs OXAZEPAM
OXALIPLATIN vs OXCARBAZEPINE
OXALIPLATIN vs OXITRIPTAN
OXALIPLATIN vs OXOMEMAZINE